Evidence map›Paper›PMID 42718696›Full record

ArticleFrontiers in immunology2026

Qingzhu granule mitigates acute gouty arthritis through HIF-1α-dependent glycolytic metabolic reprogramming of M1 macrophages.

Yulin Qi, Wenwen Li, Qing Wang, Shuiping Zhou, Yuhong Li, Lin Li

Erratum issuedAbstract read
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Yulin QiKey Laboratory of Traditional Chinese Medical Pharmacology, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Wenwen LiKey Laboratory of Traditional Chinese Medical Pharmacology, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Qing WangState Key Laboratory of Chinese Medicine Modernization, Tasly Pharmaceutical Group Co. Ltd, Tianjin, China.
Shuiping ZhouState Key Laboratory of Chinese Medicine Modernization, Tasly Pharmaceutical Group Co. Ltd, Tianjin, China.
Yuhong LiKey Laboratory of Traditional Chinese Medical Pharmacology, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Lin LiKey Laboratory of Traditional Chinese Medical Pharmacology, Tianjin University of Traditional Chinese Medicine, Tianjin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Acute gouty arthritis (AGA) is an acute inflammatory disorder triggered by the deposition of monosodium urate crystals (MSU) in the joints, clinically characterized by severe pain and transient limitation of joint mobility. Without proper intervention, recurrent episodes can lead to irreversible joint deformities, posing a serious threat to the health of patients. Qingzhu granule (QZG), a traditional Chinese medicinal formula, has been clinically applied in the management of AGA, yet its underlying anti-inflammatory mechanisms remain poorly understood. Aim of the study: This study aims to investigate the therapeutic effects of QZG on MSU-induced AGA and to elucidate its underlying anti-inflammatory mechanisms. Methods: The AGA mouse model was established via intra-articular MSU injection. Swelling index measurement, histopathological staining and pro-inflammatory factor tests (IL-1β, TNF-α and IL-6) were employed to elucidate the therapeutic effects of QZG on AGA. Bioactive components of QZG were identified using UPLC-Q-TOF-MS analysis, while network pharmacology and bioinformatics approaches were employed to predict its potential targets and pathways. Subsequently, flow cytometry and immunofluorescence were applied to determine the proportion of M1 and M2 macrophages in the ankle joints of AGA mice. MSU-stimulated RAW264.7 cells were used to further verify the direct effect of QZG on M1 macrophage polarization. After detecting the effects of QZG on glycolysis and oxidative phosphorylation in macrophages, the expression of glycolysis-related enzymes was also examined. The potential upstream targets of glycolysis-related genes regulated by QZG were predicted using protein-protein interaction network analysis, random forest algorithm, and ChEA3 database. Finally, HIF-1α overexpression plasmids were utilized to confirm that HIF-1α serves as a key target mediating the regulatory effects of QZG. Results: QZG significantly alleviated ankle swelling, reduced immune cell infiltration, and decreased pro-inflammatory factor levels (IL-1β, TNF-α and IL-6) in MSU-induced AGA mice. UPLC-Q-TOF-MS analysis identified 30 bioactive constituents in QZG. Network pharmacology and bioinformatics analysis suggested that macrophage polarization may be the key pathway for the anti-inflammatory effects of QZG. QZG effectively reduced the proportion of M1 macrophages in ankle joints of AGA mice, which was further validated in MSU-stimulated RAW264.7 cells. Moreover, glycolysis capacity was decreased after QZG intervention in RAW264.7 cells. Meanwhile, QZG suppressed the mRNA and protein expression of glycolysis-related enzymes Conclusion: QZG alleviates MSU-induced local inflammation in AGA by suppressing HIF-1α-dependent glycolysis and M1 macrophage polarization.

Indexed as

Anti-Inflammatory AgentsArthritis, GoutyDrugs, Chinese HerbalGlycolysisHypoxia-Inducible Factor 1, alpha SubunitMacrophagesAnimalsCytokinesDisease Models, AnimalMaleMiceRAW 264.7 CellsUric AcidAnti-Inflammatory AgentsCytokinesDrugs, Chinese HerbalHif1a protein, mouseHypoxia-Inducible Factor 1, alpha SubunitUric Acidacute gouty arthritis (AGA)glycolysisHIF-1αM1 macrophage polarizationQingzhu granule (QZG)

Identifiers

PMID42718696
PMCPMC13553399

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.